<dmn:definitions xmlns:dmn="https://www.omg.org/spec/DMN/20240513/MODEL/" namespace="http://smart.who.int/immunizations" label="IMMZ.D5 Determine vaccine(s) to be administered based on contraindications" id="DTs.HPV">
  <dmn:decision id="DT.IMMZ.D5.DT.HPVcontraindications" label="IMMZ.D5 Determine vaccine(s) to be administered based on contraindications">
    <dmn:question>IMMZ.D5 Determine vaccine(s) to be administered based on contraindications</dmn:question>
    <dmn:usingTask href="http://smart.who.int/immunizations/bpmn/Check.bpmn#for%20contraindications%20before%20administering%20the%20vaccine%28s%29%20due"/>
    <dmn:decisionTable id="DT.IMMZ.D5.DT.HPVcontraindications">
      <dmn:input id="input.PotentialcontraindicationsDT.IMMZ.D5.DT.HPVc.31a89d3e87." label="Potential contraindications"/>
      <dmn:rule id="rule.contra.DT.IMMZ.D5.DT.HPVcontraindications.2">
        <dmn:inputEntry>
          <dmn:description>"Potential contraindications" = "Severe allergic reactions"</dmn:description>
          <dmn:text>The client has history of severe allergic reactions</dmn:text>
        </dmn:inputEntry>
        <dmn:outputEntry>
          <dmn:description>"Immunization recommendation status" = "Further evaluation needed"</dmn:description>
          <dmn:text>HPV vaccination could be contraindicated. Clinical judgement is required. Create a clinical note</dmn:text>
        </dmn:outputEntry>
        <dmn:annotationEntry>
          <dmn:text>–</dmn:text>
        </dmn:annotationEntry>
        <dmn:annotationEntry>
          <dmn:text>Human papillomavirus vaccines: WHO position paper (December 2022) (15)</dmn:text>
        </dmn:annotationEntry>
        <dmn:outputEntry>
          <dmn:description>Do not vaccinate client with HPV if client has history of a severe allergic reaction after a previous HPV vaccine dose, or to a component of the vaccine.</dmn:description>
          <dmn:text>Do not vaccinate client with HPV if client has history of a severe allergic reaction after a previous HPV vaccine dose, or to a component of the vaccine.</dmn:text>
        </dmn:outputEntry>
        <dmn:annotationEntry>
          <dmn:text>–</dmn:text>
        </dmn:annotationEntry>
        <dmn:annotationEntry>
          <dmn:text>Human papillomavirus vaccines: WHO position paper (December 2022) (15)</dmn:text>
        </dmn:annotationEntry>
      </dmn:rule>
    </dmn:decisionTable>
  </dmn:decision>
</dmn:definitions>